Skip to main content

Hanson & Doremus Investment Management

Position in ABBV — AbbVie Inc.

CIK 1393944 BURLINGTON, VT

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$4,172,442
+$758,284 QoQ
Shares Held
16,581
+5.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#1,427
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. ABBV ranks #3 (14.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ABBV
AbbVie Inc.
This page
16,581 $4,172,442

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,172,442 16,581
2026-03-31 $3,414,158 15,698
2025-12-31 $3,658,810 16,013
2025-09-30 $3,710,891 16,027
2025-06-30 $2,955,812 15,924
2025-03-31 $3,348,339 15,981
2024-12-31 $1,573,533 8,855
2024-09-30 $1,445,356 7,319
2024-06-30 $1,263,930 7,369
2024-03-31 $1,363,564 7,488
2023-12-31 $1,200,862 7,749
2023-09-30 $1,169,822 7,848
2023-06-30 $1,018,558 7,560
2023-03-31 $1,292,650 8,111
2022-12-31 $1,406,168 8,701
2022-09-30 $1,245,200 9,278
2022-06-30 $1,376,908 8,990
2022-03-31 $1,453,964 8,969
2021-12-31 $1,016,177 7,505
2021-09-30 $835,345 7,744
2021-06-30 $888,616 7,889
2021-03-31 $870,954 8,048
2020-12-31 $867,486 8,096
2020-09-30 $690,997 7,889
2020-06-30 $780,531 7,950
2020-03-31 $665,595 8,736